Tokyo, Japan:  We at Global Regulatory Partners sincerely extend our sympathies to everyone affected by the Kumamoto earthquake that occurred on July 28, 2026. 

We also express our heartfelt condolences to those who lost their lives due to this earthquake and offer our deepest sympathy to their families. 

At this time, there has been no confirmed impact on the supply of pharmaceuticals handled by Global Regulatory Partners GK. 

We sincerely hope for the swift recovery and reconstruction of the affected areas.

ABOUT GLOBAL REGULATORY PARTNERS
Global Regulatory Partners (GRP) is a leading provider of integrated regulatory affairs, compliance, and commercialization solutions for pharmaceutical, biotechnology, and medical device companies entering Japan. By serving as a Market Authorization Holder (MAH) in Japan, GRP simplifies market entry, accelerates regulatory approval timelines, and enables faster patient access to innovative healthcare products throughout the product lifecycle.
To learn more about Global Regulatory Partners and its services in Japan, visit globalregulatorypartners.co.jp.